MétaCan
← all works

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study

2020· article· en· 624 citations· W3034965161 on OpenAlex· 10.1016/s1470-2045(20)30314-4

Why is this work in the frame?

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

Canadian funderA Canadian agency funded it. The work may carry no Canadian affiliation at all.

No Canadian affiliation. An affiliation-only frame — the usual design — would never have seen this work. It is one of the works that make the case for inverting the frame.

Machine scores (provisional)

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Opus teacher head0.104
GPT teacher head0.430
Teacher spread
0.326 · how far apart the two teachers sit on this one work
Validation status
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Abstract

No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.

The record

Venue
The Lancet Oncology
Topic
COVID-19 and healthcare impacts
Field
Medicine
Canadian institutions
Funders
Foundation MedicineMerck Sharp and DohmeBristol-Myers Squibb CanadaGrifolsPharmaMarOtsuka PharmaceuticalEisaiInstitut National de la Santé et de la Recherche MédicaleG1 TherapeuticsClovis OncologyLes Laboratories Pierre FabreRegeneron PharmaceuticalsTakeda Pharmaceutical CompanyAbbVieSamsungBristol-Myers SquibbEuropean Respiratory SocietyMerckSpectrum PharmaceuticalsBayerGilead SciencesCelgeneNovartisExelixisSanofiRoche ItaliaGlaxoSmithKlinePfizerIncyteStanford UniversityAmgenAstraZenecaEli Lilly and Company
Keywords
MedicineLung cancerInternal medicineCohortCancer registryPneumoniaOdds ratioPopulationCancerComorbidityStage (stratigraphy)
Has abstract in OpenAlex
no